Tg Therapeutics shares fall 1.07% premarket after CEO to participate in H.C. Wainwright 27th Annual Global Investment Conference.

viernes, 5 de septiembre de 2025, 6:15 am ET1 min de lectura
TGTX--
Tg Therapeutics, Inc. declined 1.07% in premarket trading. The company announced that its Chairman and CEO, Michael S. Weiss, will participate in the H.C. Wainwright 27th Annual Global Investment Conference in New York on September 8-10, 2025. The fireside chat is scheduled for September 8 at 10:30am ET.

Tg Therapeutics shares fall 1.07% premarket after CEO to participate in H.C. Wainwright 27th Annual Global Investment Conference.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios